4/A//SEC Filing
ACHILLION PHARMACEUTICALS INC 4/A
Accession 0001181431-14-029377
CIK 0001070336operating
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:05 PM ET
Size
12.4 KB
Accession
0001181431-14-029377
Insider Transaction Report
Form 4/AAmended
FRASHIER GARY E
Director
Transactions
- Exercise/Conversion
Common Stock
2014-06-16$1.05/sh+3,750$3,938→ 8,750 total - Sale
Common Stock
2014-06-16$8.00/sh−3,750$30,000→ 5,000 total - Exercise/Conversion
Common Stock
2014-06-16$3.28/sh+16,250$53,300→ 21,250 total - Sale
Common Stock
2014-06-16$8.00/sh−16,250$130,000→ 5,000 total - Exercise/Conversion
Common Stock
2014-06-16$3.10/sh+35,000$108,500→ 40,000 total - Sale
Common Stock
2014-06-16$8.00/sh−35,000$280,000→ 5,000 total
Footnotes (1)
- [F1]This amendment is being filed solely to correct Table I, column 5 of the Form 4 filed on June 17, 2014 (the "Original Form 4"). The amounts shown in Table I, column 5 of the Original Form 4 inadvertently omitted 5,000 shares of common stock beneficially owned by the reporting person. The amounts shown in Table I, column 5 of this amendment represent the correct number of shares of common stock beneficially owned by the reporting person following the transactions previously reported in Table I, column 5 of the Original Form 4. Except for the foregoing, no new or revised transactions or holdings are being reported by this amendment, and all other information reported in the Original Form 4 remains the same.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070336
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 6:05 PM ET
- Size
- 12.4 KB